Skip to content

Follow Up 5 days after beginning of Tx.

DEVICE2 trials

Sponsors

Universidad Central de Venezuela, University of Rome Tor Vergata

Conditions

HIV SeropositivityTuberculosis, Pulmonarye-Nose